KRAS and colorectal carcinoma: Strikingly, p53‐WT CRC had a much higher protein level of METTL14 compared with p53‐MT samples (Fig 1J), while no differences were found between KRAS‐WT and KRAS‐MT CRC samples in Cohort 3 (Appendix Fig S3A).